Seroprevalence of anti-SARS-CoV-2 in patients with hepatitis B and C: a pre-vaccination study
Lucas Lima da Silva, Lia Laura Lewis-Ximenez, Mônica de Avelar Figueiredo Mafra Magalhães, Vanessa Salete de Paula, Livia Melo Villar

TL;DR
This study found a high rate of prior SARS-CoV-2 exposure in hepatitis B and C patients before vaccination, especially in older adults and those in disadvantaged areas of Rio de Janeiro.
Contribution
The study provides new insights into SARS-CoV-2 seroprevalence in hepatitis B and C patients during the pre-vaccination phase of the pandemic.
Findings
24.1% of hepatitis B and C patients tested positive for anti-SARS-CoV-2 antibodies before vaccination.
Older individuals (over 40 years) had a higher seroprevalence (16.58%) compared to younger individuals.
The highest detection rate occurred in November 2020, primarily in impoverished neighborhoods of Rio de Janeiro.
Abstract
The serological markers for the diagnosis of COVID-19 plays an important role in the epidemiological investigation of the pandemic. This study aims to assess the prevalence of anti-SARS-CoV-2 in hepatitis B and C patients in a pre-vaccination of COVID-19 period. Between March 2020 and January 2021, 199 serum samples from individuals with HBsAg/HBV DNA or anti-HCV/HCV RNA positivity were tested for antibodies (IgM and IgG) against SARS-CoV-2 using Electrochemiluminescent Immunoassay (ECLIA). Among these, 50.3 % (100/199) tested positive for hepatitis C virus infection and 49.7 % (99/199) for hepatitis B virus, confirmed through molecular and serological diagnosis. The anti-SARS-CoV-2 seroprevalence was 24.1 % (48/199) in this population, with 23.23 % (23/99) hepatitis B and 25 % (25/100) hepatitis C patients tested positive for anti-SARS-CoV-2. The higher seroprevalence of…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSARS-CoV-2 and COVID-19 Research · COVID-19 Clinical Research Studies · SARS-CoV-2 detection and testing
